Research progress on molecular characteristics and biological functions of LERK-3

LERK-3（Leukocyte-derived epidermal growth factor-like receptor kinase-3 ligand） It is a member of the epidermal growth factor like family and an important ligand of the neurotrophic factor receptor tyrosine kinase (Trk) family.

Recent Advances
Product Information

Recent Advances

Advances in Research on Molecular Characteristics and Biological Functions of LERK-3

I. Definition and Molecular Structural Characteristics of LERK-3

LERK-3 (Leukocyte-derived epidermal growth factor-like receptor kinase-3 ligand) is a member of the epidermal growth factor-like family and an important ligand of the neurotrophin receptor tyrosine kinase (Trk) family. As a type of secretory glycoprotein, LERK-3 was initially discovered in leukocyte-derived cell lines. Its encoding gene is located in a specific region of human chromosomes and contains multiple conserved structural domains, among which the epidermal growth factor-like (EGF-like) domain is the core region for exerting biological functions.

The molecular structure of LERK-3 has typical characteristics of the EGF family, including a signal peptide sequence, multiple cysteine-rich EGF-like repeat sequences, and a carboxyl-terminal regulatory region. These structural features enable it to bind to specific receptors on the surface of target cells and initiate downstream signal transduction pathways. Studies have shown that glycosylation modification of LERK-3 plays an important regulatory role in its secretion, stability, and receptor-binding ability, and different post-translational modification states can affect its biological activity.

II. Expression Pattern and Physiological Functions of LERK-3

(1) Tissue Expression Distribution Characteristics

LERK-3 has a wide tissue expression profile in the body but shows obvious spatiotemporal specificity. During embryonic development, LERK-3 is mainly expressed in the nervous system, cardiovascular system, and skeletal development regions, suggesting its important role in embryonic tissue differentiation. In adult individuals, LERK-3 maintains a certain expression level in the brain, heart, kidneys, and immune tissues, with the highest expression in the central nervous system, especially in brain regions related to neural plasticity such as the hippocampus and cortex.

Under physiological conditions, the expression of LERK-3 is regulated by various factors, including extracellular signal stimulation, inflammatory factors, and hormone levels. Under stress conditions, the expression level of LERK-3 in specific tissues undergoes dynamic changes to regulate cell functions and adapt to environmental changes, a characteristic that makes it an important regulatory factor for maintaining internal environment stability.

(2) Main Biological Functions

LERK-3 exerts biological functions by binding to Trk family receptors (mainly TrkA and TrkB) on the surface of target cells, participating in various physiological processes such as cell proliferation, differentiation, survival, and migration. In the nervous system, as a neurotrophin-like molecule, LERK-3 can promote the growth of neuronal processes, maintain neuronal survival, and participate in the regulation of synapse formation and plasticity, which is of great significance for maintaining learning and memory functions.

In the cardiovascular system, LERK-3 regulates vascular endothelial cell function by activating the Trk receptor pathway, promotes angiogenesis, and maintains vascular wall integrity. Studies have found that LERK-3 can inhibit the abnormal proliferation of vascular smooth muscle cells and play a protective role in vascular injury repair. In addition, LERK-3 also plays a role in the immune system, regulating the activation and differentiation of immune cells and participating in the fine regulation of immune responses.

III. Association between LERK-3 and Disease Occurrence and Development

(1) Role in Nervous System Diseases

A large number of studies have shown that abnormal LERK-3 expression is closely related to various nervous system diseases. In the brain tissue of patients with Alzheimer's disease, the expression level of LERK-3 is significantly reduced, and it is positively correlated with the degree of neuronal degeneration, suggesting that its expression deficiency may exacerbate the nerve damage process. Studies on Parkinson's disease models have shown that exogenous supplementation of LERK-3 can reduce the loss of dopaminergic neurons and improve motor dysfunction, providing a potential target for disease treatment.

In ischemic stroke models, the expression of LERK-3 in the injured area shows a dynamic change of first increasing and then decreasing. Early high expression may play a neuroprotective role by promoting angiogenesis and nerve repair, while insufficient expression in the later stage may affect the functional recovery process. These findings reveal the dual regulatory role of LERK-3 in nervous system diseases.

(2) Related Research on Cardiovascular Diseases

The role of LERK-3 in cardiovascular diseases has gradually attracted attention. Studies on atherosclerotic models have shown that the downregulation of LERK-3 expression in diseased vascular regions leads to vascular endothelial dysfunction and uncontrolled proliferation of vascular smooth muscle cells. Exogenous supplementation of LERK-3 can improve endothelial cell function by activating the TrkA pathway, inhibit inflammatory responses and foam cell formation, and delay the progression of atherosclerosis.

In patients with heart failure, the expression level of LERK-3 in myocardial tissue is significantly reduced and positively correlated with cardiac function indicators. Animal experiments have confirmed that LERK-3 can inhibit myocardial cell apoptosis through the TrkB receptor signaling pathway, promote myocardial repair, and improve cardiac function, suggesting that it may become a new target for heart failure treatment.

IV. Research Methods and Technical Means for LERK-3

Commonly used techniques for studying LERK-3 include molecular biology, cell biology, and animal model research methods. At the molecular level, real-time quantitative PCR and Western blot are used to detect the gene expression and protein level of LERK-3; immunohistochemical technology can clarify its localization and distribution in tissues. In cell experiments, recombinant LERK-3 protein is commonly used to treat cells, and flow cytometry and cell scratch experiments are combined to evaluate its impact on cell functions.

Animal model research is an important means to analyze the physiological functions of LERK-3, including gene knockout mice, conditional knockout models, and disease model intervention experiments. Through these models, the impact of LERK-3 deficiency or overexpression on tissue development and disease progression can be observed at the overall level. In recent years, the application of CRISPR/Cas9 gene editing technology has further improved the accuracy of LERK-3 function research, providing a powerful tool for in-depth exploration of its mechanism of action.

V. Research Progress and Future Prospects

In recent years, research on LERK-3 has made certain progress, and its functions in neuroprotection and vascular repair have gradually become clear, providing a new perspective for the mechanism research of related diseases. Current research mainly focuses on its regulatory role in cell survival and proliferation, while exploration of its functions in metabolic regulation and immune regulation is still in its infancy.

Future research can focus on three directions: first, in-depth analysis of the molecular mechanism of LERK-3 binding to receptors, and clarification of receptor specificity and signaling pathway differences in different tissues; second, exploration of the possibility of LERK-3 as a disease biomarker to achieve early diagnosis and prognosis evaluation of diseases by detecting its expression level; third, development of LERK-3-based targeted therapy strategies, such as recombinant protein drugs and small molecule agonists, to provide new approaches for the treatment of nervous system and cardiovascular diseases.

Although there are still many unknowns in the research of LERK-3, with the innovation of technical methods and the expansion of research depth, its biological functions and clinical value will be more comprehensively revealed, providing an important theoretical basis for life science research and disease treatment.

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next